Patents-Review.com
ClassID:

110143 ⎘

C12N2720/12232 - CPC Classification

Classification description:

dsRNA viruses; Details; Reoviridae; Orthoreovirus, e.g. mammalian orthoreovirus Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Recent Application in this class:
#1
20240293462
2024-09-05

Immune Cell Fusion (ICF) and Uses Thereof

 #2
20210008136
2021-01-14

Oncolytic reovirus

 #3
20200237917
2020-07-30

Reoviruses having modified sequences

 #4
20180214538
2018-08-02

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

 #5
20170049829
2017-02-23

Attenuated reovirus

 #6
20150224155
2015-08-13

Liquid viral formulations

 #7
20150037355
2015-02-05

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

 #8
20130017172
2013-01-17

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

 #9
20120225045
2012-09-06

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

 #10
20120141426
2012-06-07

Reovirus for the treatment of cellular proliferative disorders

 #11
20120141421
2012-06-07

Liquid viral formulations

 #12
20110243890
2011-10-06

Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus

 #13
20110020288
2011-01-27

Reoviruses having modified sequences

 #14
20110014155
2011-01-20

Reovirus for the treatment of cellular proliferative disorders

 #15
20100248205
2010-09-30

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

 #16
20100021432
2010-01-28

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

 #17
20090214479
2009-08-27

Attenuated reovirus

 #18
20090117082
2009-05-07

Reovirus for the treatment of cellular proliferative disorders

 #19
20090110665
2009-04-30

REOVIRUS FOR THE TREATMENT OF NEOPLASIA

 #20
20090098089
2009-04-16

REOVIRUS FOR THE TREATMENT OF NEOPLASIA

 #21
20090035278
2009-02-05

REOVIRUSES HAVING MODIFIED SEQUENCES

 #22
20080226602
2008-09-18

Reoviruses having modified sequences

 #23
20080081032
2008-04-03

Method for reducing pain using oncolytic viruses

 #24
20080075729
2008-03-27

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

 #25
20080057073
2008-03-06

Methods for the treatment of cellular proliferative disorders

 #26
20080038822
2008-02-14

Virus clearance of neoplastic cells from mixed cellular compositions

 #27
20080032279
2008-02-07

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

 #28
20080031851
2008-02-07

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

 #29
20080026048
2008-01-31

Reovirus for the treatment of cellular proliferative disorders

 #30
20070280952
2007-12-06

Modified reoviral therapy

 #31
20060172288
2006-08-03

Methods for the treatment of cellular proliferative disorders

 #32
20060073166
2006-04-06

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

 #33
20060029598
2006-02-09

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

 #34
20050123513
2005-06-09

Reovirus for the treatment of neoplasia

 #35
20050095692
2005-05-05

Method of extracting virus from cell culture

 #36
20050063954
2005-03-24

Reovirus for the treatment of cellular proliferative disorders

 #37
20050026289
2005-02-03

Virus clearance of neoplastic cells from mixed cellular compositions

 #38
20050019308
2005-01-27

Oncolytic viruses for the treatment of neoplasms having activated PP2A or Rac